PDF下载 ( 1134 KB)
New evidence of FibroScan′s clinical value for assessing fibrosis, screening liver disease, monitoring chronic liver disease progression, and predicting outcome
-
摘要:
<正>FibroScan是目前应用最广泛的无创纤维化诊断手段之一。人们对FibroScan的应用已经不仅仅是评估纤维化,而且可以预测肝硬化相关并发症和肝细胞癌(HCC)的存在,更重要的是可以预测临床预后。换句话说,FibroScan不仅可以评
-
Key words:
- liver cirrhosis /
- liver diseases
-
[1]Castera L.Noninvasive methods to assess liver disease inpatients with hepatitis B or C[J].Gastroenterology, 2012, 142 (6) :1293-1302.e4. [2]Colombo S, Belloli L, Zaccanelli M, et al.Normal liver stiff-ness and its determinants in healthy blood donors[J].DigLiver Dis, 2011, 43 (3) :231-236. [3]Das K, Sarkar R, Ahmed SM, et al.“Normal”liver stiffnessmeasure (LSM) values are higher in both lean and obese in-dividuals:a population-based study from a developing coun-try[J].Hepatology, 2012, 55 (2) :584-593. [4]Friedrich-Rust M, Ong MF, Martens S, et al.Performance oftransient elastography for the staging of liver fibrosis:a meta-analysis[J].Gastroenterology, 2008, 134 (4) :960-974. [5]Zhu X, Wang LC, Chen EQ, et al.Prospective evaluation ofFibroScan for the diagnosis of hepatic fibrosis compared withliver biopsy/AST platelet ratio index and FIB-4 in patientswith chronic HBV infection[J].Dig Dis Sci, 2011, 56 (9) :2742-2749. [6]Wong GL, Wong VW, Choi PC, et al.Development of a non-invasive algorithm with transient elastography (FibroScan) and serum test formula for advanced liver fibrosis in chronichepatitis B[J].Aliment Pharmacol Ther, 2010, 31 (10) :1095-1103. [7]Castera L.Assessing liver fibrosis[J].Expert Rev Gastroen-terol Hepatol, 2008, 2 (4) :541-552. [8]Cardoso AC, Carvalho-Filho RJ, Stern C, et al.Direct com-parison of diagnostic performance of transient elastography inpatients with chronic hepatitis B and chronic hepatitis C[J].Liver Int, 2012, 32 (4) :612-621. [9]Kim SU, Park JY, Kim do Y, et al.Non-invasive assess-ment of changes in liver fibrosis via liver stiffness measure-ment in patients with chronic hepatitis B:impact of antiviraltreatment on fibrosis regression[J].Hepatol Int, 2010, 4 (4) :673-680. [10]Gaia S, Carenzi S, Barilli AL, et al.Reliability of transientelastography for the detection of fibrosis in non-alcoholicfatty liver disease and chronic viral hepatitis[J].J Hepatol, 2011, 54:64-71. [11]Wong GL, Wong VW, Chan HL.Is transient elastography in-accurate in chronic hepatitis B and non-alcoholic fatty liverdisease?[J].J Hepatol, 2011, 55 (2) :497. [12]Castéra L, Vergniol J, Foucher J, et al.Prospective comparisonof transient elastography, Fibrotest, APRI, and liver biopsy forthe assessment of fibrosis in chronic hepatitis C[J].Gastroen-terology, 2005, 128 (2) :343-350. [13]Castéra L, Sebastiani G, Le Bail B, et al.Prospective com-parison of two algorithms combining non-invasive methodsfor staging liver fibrosis in chronic hepatitis C[J].J Hepatol, 2010, 52 (2) :191-198. [14]Roulot D, Costes JL, Buyck JF, et al.Transient elastogra-phy as a screening tool for liver fibrosis and cirrhosis in acommunity-based population aged over 45 years[J].Gut, 2011, 60 (7) :977-984. [15]Foucher J, Chanteloup E, Vergniol J, et al.Diagnosis of cir-rhosis by transient elastography (FibroScan) :a prospectivestudy[J].Gut, 2006, 55 (3) :403-408. [16]Vizzutti F, Arena U, Romanelli RG, et al.Liver stiffness measure-ment predicts severe portal hypertension in patients with HCV-related cirrhosis[J].Hepatology, 2007, 45 (5) :1290-1297. [17]Sánchez-Conde M, Miralles P, Bellón JM, et al.Use oftransient elastography (FibroScanVR) for the noninvasiveassessment of portal hypertension in HIV/HCV-coinfectedpatients[J].J Viral Hep, 2011, 18:685-691. [18]Kim do Y, Kim SU, Ahn SH, et al.Usefulness of FibroScanfor detection of early compensated liver cirrhosis in chronichepatitis B[J].Dig Dis Sci, 2009, 54 (8) :1758-1763. [19]Robic MA, Procopet B, Métivier S, et al.Liver stiffness ac-curately predicts portal hypertension related complications inpatients with chronic liver disease:a prospective study[J].J Hepatol, 2011, 55:1017-1024. [20]Merchante N, Rivero-Juárez A, Téllez F, et al.Liver stiff-ness predicts clinical outcome in human immunodeficiencyvirus/hepatitis C virus-coinfected patients with compensa-ted liver cirrhosis[J].Hepatology, 2012, 56 (1) :228-238. [21]Corpechot C, Carrat F, Poujol-Robert A, et al.Noninvasiveelastography-based assessment of liver fibrosis progressionand prognosis in primary biliary cirrhosis[J].Hepatology, 2012, 56 (1) :198-208. [22]Jung KS, Kim SU, Ahn SH, et al.Risk assessment of hepa-titis B virus-related hepatocellular carcinoma developmentusing liver stiffness measurement (FibroScan) [J].Hepatol-ogy, 2011, 53 (3) :885-894. [23]Masuzaki R, Tateishi R, Yoshida H, et al.Prospective riskassessment for hepatocellular carcinoma development in pa-tients with chronic hepatitis C by transient elastography[J].Hepatology, 2009, 49 (6) :1954-1961. [24]Jung KS, Kim SU, Choi GH, et al.Prediction of Recurrenceafter Curative Resection of Hepatocellular Carcinoma usingLiver Stiffness Measurement (FibroScan (?) ) [J].Ann SurgOncol, 2012, Jul 3.[Epub ahead of print] [25]Wong GL, Wong VW, Choi PC, et al.Assessment of fibro-sis by transient elastography compared with liver biopsy andmorphometry in chronic liver diseases[J].Clin GastroenterolHepatol, 2008, 6 (9) :1027-1035. [26] Wong GL, Wong VW, Choi PC, et al.Increased liver stiff-ness measurement by transient elastography in severe acuteexacerbation of chronic hepatitis B[J].J Gastroenterol Hep-atol, 2009, 24 (6) :1002-1007. [27]Wong GL, Wong VW, Chim AM, et al.Factors associatedwith unreliable liver stiffness measurement and its failurewith transient elastography in the Chinese population[J].JGastroenterol Hepatol, 2011, 26 (2) :300-305. [28]de Lédinghen V, Wong VW, Vergniol J, et al.Diagnosis ofliver fibrosis and cirrhosis using liver stiffness measurement:comparison between M and XL probe of FibroScan?[J].JHepatol, 2012, 56 (4) :833-839. -
本文二维码
计量
- 文章访问数: 3094
- HTML全文浏览量: 14
- PDF下载量: 900
- 被引次数: 0
下载:
